Logo
Secure Registration

International Conference on HIV and Epidemiology Studies

6th Apr – 7th Apr 2027 Sao Luis, Brazil

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

4

Terms & Condition

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9 SDG 10
01 Advancements in HIV Epidemiology +

This track focuses on the latest research findings in HIV epidemiology, highlighting trends, risk factors, and population dynamics. Participants will discuss innovative methodologies for data collection and analysis in the context of HIV transmission.

02 Molecular Diagnostics in HIV Management +

This session will explore cutting-edge molecular diagnostic techniques for HIV detection and monitoring. Emphasis will be placed on the role of these technologies in improving patient outcomes and guiding treatment decisions.

03 Clinical Research Innovations in HIV Treatment +

This track will showcase recent clinical trials and studies that have contributed to the advancement of HIV treatment protocols. Discussions will include the efficacy and safety of novel therapeutic agents and combination therapies.

04 Public Health Interventions for HIV Prevention +

This session will examine effective public health strategies aimed at reducing HIV transmission rates. Participants will share successful case studies and evaluate the impact of community-based interventions.

05 Laboratory Techniques in HIV Research +

This track will delve into the laboratory methodologies employed in HIV research, including viral load testing and resistance testing. Attendees will discuss the implications of these techniques for clinical practice and research.

06 Translational Research in HIV +

This session will focus on the translation of basic research findings into clinical applications for HIV prevention and treatment. Participants will explore the challenges and successes of bridging the gap between laboratory discoveries and patient care.

07 Behavioral Studies and HIV Risk Reduction +

This track will investigate the behavioral factors influencing HIV risk and the effectiveness of interventions designed to promote safer practices. Research on stigma, education, and community engagement will be highlighted.

08 Patient Monitoring and Long-term Care in HIV +

This session will address the importance of ongoing patient monitoring and management in the context of HIV care. Discussions will include strategies for enhancing adherence to treatment and improving quality of life for patients.

09 Policy Development for HIV Programs +

This track will explore the role of policy in shaping effective HIV prevention and treatment programs. Participants will discuss the implications of current policies and advocate for evidence-based changes to improve public health outcomes.

10 Global Perspectives on HIV Epidemiology +

This session will provide a platform for discussing global trends and disparities in HIV epidemiology. Researchers will share insights from various regions, emphasizing the need for tailored interventions.

11 Emerging Technologies in HIV Research +

This track will highlight the role of emerging technologies, such as artificial intelligence and big data analytics, in HIV research. Discussions will focus on how these innovations can enhance our understanding and management of the epidemic.